# Novo Nordisk Inc.

Canonical: https://abierto.us/vendors/novo-nordisk-inc-w72bjmjybmn3

- UEI: W72BJMJYBMN3
- CAGE: 60554
- Parent: Novo Nordisk Fonden
- Location: Plainsboro, NJ
- Awards in window: 5 (85 transactions), $0 obligated, January 3, 2024 to August 24, 2026

## Awarding agencies

- Department of Veterans Affairs: 5 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 5 awards

## Largest awards

- 36E79720D0018: $0, Nac Pharmaceuticals. Implement Cost Recovery Fee (Crf) Changes Mod.. https://www.usaspending.gov/award/CONT_IDV_36E79720D0018_3600/
- 36E79720D0071: $0, Nac Pharmaceuticals. This Modification Is Issued to Incorporate Novo Nordisk'S 2024 Subcontracting Plan Effective for the Period of January 1, 2024 - December 31, 2024.. https://www.usaspending.gov/award/CONT_IDV_36E79720D0071_3600/
- 36E79725A0025: $0, Nac Pharmaceuticals. BPA for Rivfloza. https://www.usaspending.gov/award/CONT_IDV_36E79725A0025_3600/
- 36F79719D0181: $0, Nac Federal Supply Schedule. FSS. https://www.usaspending.gov/award/CONT_IDV_36F79719D0181_3600/
- 36F79721D0044: $0, Nac Federal Supply Schedule. FSS. https://www.usaspending.gov/award/CONT_IDV_36F79721D0044_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/novo-nordisk-inc-w72bjmjybmn3.